InvestorsHub Logo
Followers 118
Posts 5283
Boards Moderated 1
Alias Born 02/11/2013

Re: Crabby!! post# 129829

Wednesday, 04/23/2014 2:42:04 PM

Wednesday, April 23, 2014 2:42:04 PM

Post# of 158400
Huge find Crabby, FDA is excited and on board for the stem cell revolution. And we have the dream team of stem cell guru's BOOM! My mother always says, it is more important to know what you are selling than what you are buying. Peeps better know what they are letting go for dirt cheap here. Cuz you cant spell REGEN without Green

Boisterous Marlin Swims North

Scientists sporting white coats and safety gloves are working in a bright Food and Drug Administration (FDA) lab on an incredible project.
They are part of FDA’s MSC Consortium, a large team of FDA scientists studying adult mesenchymal stem cells (MSCs)—cells that could eventually be used to repair, replace, restore or regenerate cells in the body, including those needed for heart and bone repair.

The scientists’ investigational work is unprecedented: Seven labs at FDA's Center for Biologics Evaluation and Research formed the consortium to fill in gaps in knowledge about how stem cells function.

“This research aims to facilitate development of this important class of innovative medical products,” explains Carolyn A. Wilson, Ph.D., associate director for research at the center. “It’s the first time we’ve done anything like this, and it’s proven to be a very useful approach. It’s worked so well because this is a huge, complicated project that requires expertise in many different technologies and methods.”

The research could ultimately be key to the advancement of personalized medicine, the practice in which medical treatment is tailored to the needs of an individual patient. “It’s not science fiction,” says Steven R. Bauer, Ph.D., chief of the Cellular and Tissue Therapy Branch in FDA’s Office of Cellular Tissue and Gene Therapies. “For me, regenerative medicine is the most exciting part of what we regulate in our office.”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.